FDA Inspection 1051855 — Meridian Clinical Research
The FDA completed an inspection of Meridian Clinical Research on May 2, 2018 in Savannah, GA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- May 2, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Savannah, GA (United States)
Additional Details
Clinical BA/BE